{"id":"W2891620699","doi":"10.1111/bjd.17149","title":"Benefit–risk profile of tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis across six clinical trials","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Plaque psoriasis; Medicine; Psoriasis; Dermatology; Clinical trial; Internal medicine; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.02159016,0.001764456,0.0101285,0.00296701,0.0003112656,0.002670015,0.0008900071,0.001608742,0.002809465],"category_scores_gemma":[0.02696178,0.0008468872,0.02308815,0.003611822,0.0005390386,0.001295579,0.001036019,0.001318389,0.0002727193],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006700178,"about_ca_system_score_gemma":0.0008098365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007742816,"about_ca_topic_score_gemma":0.001180712,"domain_scores_codex":[0.9827938,0.009698106,0.003409945,0.00190985,0.001853244,0.0003351844],"domain_scores_gemma":[0.9766915,0.01537013,0.005480644,0.001137509,0.0009858811,0.000334341],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.1249212,0.0001394743,0.02921749,0.0237259,0.787389,0.0001507757,0.00007918438,0.002051908,0.0009577753,0.0001434611,0.001228798,0.02999499],"study_design_scores_gemma":[0.0422269,0.004864206,0.07702244,0.002068595,0.866769,0.0004401393,0.00009475771,0.001770821,0.0005001343,0.001008744,0.003136263,0.00009802864],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2735086,0.7041205,0.006265981,0.0008088342,0.000579547,0.002175906,0.008172131,0.0002662617,0.004102242],"genre_scores_gemma":[0.924212,0.06499496,0.002388311,0.000863904,0.00049324,0.001950853,0.004408987,0.00008065478,0.0006070862],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9982355,"threshold_uncertainty_score":0.114181,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02365634027330009,"score_gpt":0.3111337158610936,"score_spread":0.2874773755877935,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}